Expression of metalloproteinases 2 and 9 and cyclooxygenase 2 in endometrial carcinoma

Int J Gynaecol Obstet. 2006 Apr;93(1):64-6. doi: 10.1016/j.ijgo.2005.12.028. Epub 2006 Mar 9.

Authors

M R Raspollini¹, T Susini, G L Taddei

Affiliation

¹ Department of Human Pathology and Oncology, University of Florence, School of Medicine, Florence, Italy. [email protected]

PMID: 16527278
DOI: 10.1016/j.ijgo.2005.12.028

No abstract available

MeSH terms

Aged
Aged, 80 and over
Carcinoma / enzymology*
Carcinoma / genetics
Carcinoma / pathology
Case-Control Studies
Cyclooxygenase 2 / genetics
Cyclooxygenase 2 / metabolism*
Cyclooxygenase 2 Inhibitors / metabolism
Endometrial Neoplasms / enzymology*
Endometrial Neoplasms / genetics
Endometrial Neoplasms / pathology
Endometrium / enzymology
Female
Gene Expression Regulation, Enzymologic
Gene Expression Regulation, Neoplastic
Humans
Immunohistochemistry
Matrix Metalloproteinase 2 / genetics
Matrix Metalloproteinase 2 / metabolism*
Matrix Metalloproteinase 9 / genetics
Matrix Metalloproteinase 9 / metabolism*
Middle Aged
Prognosis
RNA, Messenger / metabolism
Reverse Transcriptase Polymerase Chain Reaction

Substances

Cyclooxygenase 2 Inhibitors
RNA, Messenger
Cyclooxygenase 2
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9